Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Abbott

Ken Paxton again tries to intervene in suit with Dallas hospital over transgender care

DALLAS — Texas Attorney General Ken Paxton is attempting for the second time to intervene in a legal fight over gender-affirming medical care at two Dallas hospitals.

Tribune News Service

Latest recalls of formula meant frantic search for family of suburban boy, 5, who needs it to survive

With help from La Rabida Children’s Hospital, Zayne Negoski of Joliet got an alternative tube-feeding formula. But his family and those of other medically needy kids have struggled and often had to pay more after Aug. 10 recall.

Chicago Sun-Times

PHILADELPHIA — The world is about to see a whole lot more from Abbott Elementary star and creator Quinta Brunson.

The Philadelphia Inquirer

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Abbott Labs A "Strong Buy" After Earnings?

Leading healthcare company Abbott Laboratories (ABT) reported strong second-quarter results. And given the company is well-positioned to capitalize on its diverse business and recent FDA approvals, is it wise to buy the stock now? Let’s find out.

StockNews.com

Abbott reports strong earnings despite infant formula crisis

Abbott Laboratories reported strong earnings Wednesday, despite spending recent months responding to criticism over problems that led to the shutdown of one of its infant formula-producing plants.

Chicago Tribune

2 Medical Stocks That Are Attractive Buys Right Now

Amid an inflationary environment, the medical sector is poised to stay afloat given the inelastic demand for medical products and services, impressive breakthroughs, and the rising need to serve an aging population. Therefore, fundamentally sound medical stocks Abbott Laboratories (ABT) and Utah Medical Products (UTMD) could be solid investments right…

StockNews.com

Is Abbott Stock a Buy at $105 as Production in Troubled Plant Resumes?

Leading healthcare company Abbott Laboratories (ABT) reported robust first-quarter results. And the company is well-positioned to benefit from its diversified business. Moreover, as ABT is resuming infant formula production at its Michigan facility, is the stock a good buy at the current price level? Read more to find out….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Quinta Brunson had the perfect response to Jimmy Kimmel's dumb Emmys bit

"I'm going to be on his show on Wednesday, so I might punch him in the face. I don't know, we’ll see what happens.”

Mic

Abbott reopens Michigan baby formula plant after flooding

Abbott's facility has now closed and reopened twice this year. The baby formula plant had previously closed in February because of bacterial contamination.

WEKU

Hopes US baby formula shortage could ease as key Abbott plant restarts

Factory in Sturgis, Michigan shut down in May after storms that produced torrential flooding

The Guardian - US

Production resumes at troubled Abbott baby formula factory

Abbot Nutrition says baby formula production has resumed at the Michigan plant whose February shutdown over contamination contributed to a national shortage

The Independent UK

This Biotech Stock Looks Like a Prime Growth Play

Diversified healthcare company Abbott (ABT) has demonstrated significant innovations across its segments, and given its dominant market position, the company’s prospects look bright. The stock could be a solid choice as it is well-positioned to survive short-term market fluctuations. Let’s discuss this in detail….

StockNews.com

This Top-Rated Healthcare Stock Is Trading at a 25% Discount

Medical device company Abbott Laboratories (ABT) reported impressive first-quarter results and affirmed its strong performance guidance for fiscal 2022. Furthermore, the company is well-positioned to benefit from its diversified business. However, amid the heightened market volatility, the stock is trading 25.5% below its 52-week high. So, the current dip in…

StockNews.com

FDA Probes Another Infant Death Given Abbott Formula, Less Than Month After Troubled Plant Reopens

Problems for Abbott Laboratories' (NYSE: ABT) Sturgis plant in Michigan for baby formula powder refuse to subside. The FDA was recently notified of another infant's death who was given formula made at Abbott's Sturgis facility.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

FDA probing death of another child said to have consumed Abbott baby Formula

Shortage of formula has created more headaches for Biden administration

Tribune News Service

FDA investigates death of another infant given Abbott formula

U.S. Food and Drug Administration officials are investigating the death of another infant who was given formula made by Abbott Laboratories.

Chicago Sun-Times

Abbott plans offices in Chicago’s Willis Tower

The medical device maker will keep its headquarters in the northern suburbs but says a downtown location works for employees who want to avoid a long commute.

The Guardian - US

Key US baby formula plant closes again as ‘torrential storms’ cause flooding

Production halt at Abbott Laboratories in Michigan will probably extend shortages for ‘a few weeks’

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Baby formula company stops production again due to storms

It is unclear when the facility will restart production

Chicago Tribune

Abbott again halting baby formula production at its Michigan facility after flooding

Less than two weeks after restarting formula production at its Michigan facility, Abbott has again had to halt manufacturing there amid flooding.

WEKU

Abbott's baby formula plant closes again after severe storms and flooding

Abbott's Sturgis, Mich., plant was open for less than two weeks before it had to close again after flooding from severe weather. The company said it hopes to resume production in a few weeks.

Tribune News Service

Baby formula production at Michigan plant delayed by severe flooding

Barely two weeks after production restarted at a Michigan plant that supplies baby formula, flooding in the area has shut down the work as supply continues to dry up nationwide.

The Independent UK

Production at bedeviled baby formula factory halted by storm

Severe weather has forced Abbott Nutrition to pause production at a Michigan baby formula factory that had just restarted

Benzinga

More Trouble For Baby Formula Production As Thunderstorms, Flood, Hit Abbott's Troubled Michigan Plant

Just a few weeks after reopening its baby formula Sturgis, Michigan plant, Abbott Laboratories (NYSE:ABT) said it paused EleCare specialty baby formula production after recent thunderstorms flooded part of the facility. The company has informed the FDA and will conduct comprehensive testing with an independent third party to ensure the plant is safe to…

Axios

Abbott halts production at Michigan baby formula plant after storm causes flooding

The beleagured Sturgis plant only resumed production less than 2 weeks ago.

1 … 7 8 9 10

People

Mangeet Kaur BounsMangeet

595 stories

Tyler Pasciak LaRiviere

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

US Food and Drug Administration

Medical – Devices & Equipment

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.